Intra-aortic Balloon Pump Utilization Prior to Coronary Artery Bypass Grafting: Social Determinants of Health

Abdul Rasheed Bahar1, Yasemin Bahar1, Hafeezuddin Ahmed2

  • 1Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, Michigan.

Insights

This study found significant disparities in the use of intra-aortic balloon pumps (IABP) before coronary artery bypass graft (CABG) surgery. Women and patients in certain regions received less IABP support, highlighting inequities in cardiovascular care.

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Health Equity

Background:

  • Disparities in healthcare access and utilization are prevalent in cardiovascular interventions.
  • Intra-aortic balloon pump (IABP) use in high-risk coronary artery bypass graft (CABG) patients varies significantly across demographic groups.
  • Social determinants of health may influence IABP utilization prior to CABG.

Purpose of the Study:

  • To examine the influence of social determinants of health on IABP utilization before CABG.
  • To investigate disparities related to sex, race, ethnicity, income, and insurance status in IABP use.

Main Methods:

  • Retrospective cohort study using the Nationwide Inpatient Sample (2016-2021).
  • Identified CABG patients with preoperative IABP use.
  • Multivariable logistic regression and propensity score matching analyzed sociodemographic factors and outcomes.

Main Results:

  • IABP was used preoperatively in 3.1% of 471,985 CABG patients.
  • Women and patients in the South/West regions had lower IABP use; Hispanic and Asian patients had higher use compared to Whites.
  • Medicaid coverage was associated with increased IABP use; income and weekend admissions showed varied associations.

Conclusions:

  • Significant sociodemographic and regional disparities exist in IABP utilization.
  • Sex-based disparities and racial/ethnic variations in IABP use require further investigation.
  • Targeted interventions are needed to ensure equitable access to advanced cardiovascular therapies.
Abstract